Latest Headlines

  1. XIFIN Leads The Way In LIS Innovation With New Solution Benefits, Strategic Partners And Continued Customer Success

    Recently, laboratories are under intense pressure to reduce costs and improve operational efficiency, all while enhancing quality and maintaining regulatory compliance

  2. Esco Ventures Announces The Launch Of Carmine Therapeutics, A Company Pioneering Red Blood Cell (RBC)-Derived Extracellular Vesicle (EV)-Based Gene Therapies

    Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of Professors Minh Leand Jiahai Shi at the City University of Hong Kong

  3. HemaCare And Charles River Laboratories Partner To Provide Human-Derived Biological Material To China

    HemaCare Corporation, a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, recently announced a distribution agreement with Charles River’s subsidiary, Vital River, to provide the scientific community in China with direct access to healthy and disease-state human primary cells

  4. Velabs Therapeutics Enters Into A Screening Cooperation With Chiome Bioscience In The Field Of GPCR-Specific Functional Antibody Screening After Successful Feasibility Study

    Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, recently announced that its cooperation with Chiome Bioscience, Inc., Tokyo, will be deepened, to jointly discover modulatory and functional antibodies for one of Chiome’s GPCR target genes

  5. First Phase Of New MRIGlobal Diagnostics Center Of Excellence Opens

    The first phase of a plan to establish a Diagnostics Center of Excellence at MRIGlobal's headquarters in Kansas City has been completed and is now fully operational

  6. ViroGates And QIAGEN Announces A Partnership To Launch suPARnostic® Quick Triage On QIAGEN’s Automated Lateral Flow (aLF) Platform

    ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency departments in hospitals, today announces that it has entered into a distribution and license agreement with QIAGEN under which ViroGates will act as an appointed distributor for QIAGEN of the aLF reader (

  7. KPMG, Coriell Life Sciences And Thermo Fisher Scientific To Collaborate On Links Between Medications And Genes

    KPMG's Clinical Intelligence (KCI) platform is helping clinicians improve the quality of care by furnishing them with pharmacogenomics data – information about how genes interact with medicines – from Coriell Life Sciences (CLS), supported by Thermo Fisher Scientific's leading genetic analysis platform and content

  8. Agilent Completes Acquisition Of BioTek Instruments

    Agilent Technologies, Inc. recently announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumentation

  9. New Diagnostic Method Predicts Cancer Therapy Response, Offering Hope For Lung Cancer Patients

    By using single-cell analysis to measure metabolic activities in rare disseminated tumor cells taken from non-small cell lung cancer (NSCLC) patients, Institute for Systems Biology (ISB) researchers and their collaborators can accurately predict how patients will respond to various cancer therapies, and how treatments will impact a patient’s physiological performance and survival

  10. Drawbridge Health Receives FDA 510(k) Clearance For OneDraw™ A1C Test System

    Drawbridge Health today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the OneDraw™ A1C Test System, comprised of the OneDraw Blood Collection Device and the OneDraw A1C Test